Skip to main navigation Skip to search Skip to main content

Can Oritavancin Be Used for Treatment and/or Suppressive Antimicrobial Therapy of Bone and Joint Infections Caused by Vancomycin-resistant Enterococcus faecium ?

  • Martin Krsak
  • , Taylor Morrisette
  • , Laura Damioli
  • , Brandon Flues
  • , Eugene W. Liu
  • , Anna Y. Zhou
  • , Abdulwhab Shremo Msdi
  • , Caleb McLeod
  • , Saagar Akundi
  • , Mark Redell
  • , Kyle C. Molina

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1225-1233
Number of pages9
JournalClinical Orthopaedics and Related Research
Volume483
Issue number7
DOIs
StatePublished - Jul 1 2025

ASJC Scopus Subject Areas

  • Surgery
  • Orthopedics and Sports Medicine

Keywords

  • Recurrence
  • Humans
  • Middle Aged
  • Male
  • Treatment Outcome
  • Arthritis, Infectious/drug therapy
  • Enterococcus faecium/drug effects
  • Osteomyelitis/drug therapy
  • Lipoglycopeptides/therapeutic use
  • Female
  • Retrospective Studies
  • Aged
  • Gram-Positive Bacterial Infections/drug therapy
  • Anti-Bacterial Agents/therapeutic use
  • Vancomycin/analogs & derivatives
  • Vancomycin-Resistant Enterococci/drug effects

Cite this